BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7548801)

  • 1. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
    Azer SA; Canfield PJ; Stacey NH
    J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
    Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
    Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.
    Manna LB; Ovadia C; Lövgren-Sandblom A; Chambers J; Begum S; Seed P; Walker I; Chappell LC; Marschall HU; Williamson C
    BJOG; 2019 Dec; 126(13):1633-1640. PubMed ID: 31483939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis.
    Ma H; Zeng M; Han Y; Yan H; Tang H; Sheng J; Hu H; Cheng L; Xie Q; Zhu Y; Chen G; Gao Z; Xie W; Wang J; Wu S; Wang G; Miao X; Fu X; Duan L; Xu J; Wei L; Shi G; Chen C; Chen M; Ning Q; Yao C; Jia J
    Medicine (Baltimore); 2016 Nov; 95(47):e5391. PubMed ID: 27893675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
    Cai SY; Mennone A; Soroka CJ; Boyer JL
    J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: a double-blind randomized controlled trial.
    Pan XL; Zhao L; Li L; Li AH; Ye J; Yang L; Xu KS; Hou XH
    J Huazhong Univ Sci Technolog Med Sci; 2013 Apr; 33(2):189-194. PubMed ID: 23592128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes.
    Bouchard G; Yousef IM; Tuchweber B
    Liver; 1993 Aug; 13(4):193-202. PubMed ID: 8377596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
    Piazza F; Montagnani M; Russo C; Azzaroli F; Aldini R; Roda E; Roda A
    Dig Liver Dis; 2000 May; 32(4):318-28. PubMed ID: 11515630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
    Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
    Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
    Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
    Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis.
    Razori MV; Maidagan PM; Ciriaci N; Andermatten RB; Barosso IR; Martín PL; Basiglio CL; Sánchez Pozzi EJ; Ruiz ML; Roma MG
    Biochem Pharmacol; 2019 Oct; 168():48-56. PubMed ID: 31202734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
    Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
    Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.
    Wimmer R; Hohenester S; Pusl T; Denk GU; Rust C; Beuers U
    Gut; 2008 Oct; 57(10):1448-54. PubMed ID: 18583398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
    Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
    J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease.
    Heubi JE; Wiechmann DA; Creutzinger V; Setchell KD; Squires R; Couser R; Rhodes P
    J Pediatr; 2002 Aug; 141(2):237-42. PubMed ID: 12183720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
    J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKCalpha-ezrin pathway.
    Baiocchi L; Tisone G; Russo MA; Longhi C; Palmieri G; Volpe A; Almerighi C; Telesca C; Carbone M; Toti L; De Leonardis F; Angelico M
    Transpl Int; 2008 Aug; 21(8):792-800. PubMed ID: 18435680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
    Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G
    Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1.
    Pusl T; Vennegeerts T; Wimmer R; Denk GU; Beuers U; Rust C
    Biochem Biophys Res Commun; 2008 Feb; 367(1):208-12. PubMed ID: 18164257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rat.
    Jacquemin E; Dumont M; Mallet A; Erlinger S
    Eur J Clin Invest; 1993 Dec; 23(12):794-802. PubMed ID: 8143756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.